Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :A4

    
• • ·Table of Contents

    Page :A6

    
• • ·Information for Readers

    Page :A29

    
• • ·JAAD Case Reports Article List

    Page :A30

    
• • ·Journal Based CME Instructions and Information

    Page :A34

    

• Continuing Medical Education

  • ·Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis

    Page :1035-1048

    Hadir Shakshouk, Alexander Hines, Shannon Kody, Nicole Fett, Afsaneh Alavi, Alex G. Ortega-Loayza

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :1049

    
  • ·Answers to CME examination

    Page :1050

    
  • ·Inflammatory and vaso-occlusive ulcers: Part II - Management

    Page :1051-1066

    Alexander Hines, Shannon Kody, Hadir Shakshouk, Nicole Fett, Afsaneh Alavi, Alex G. Ortega-Loayza

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :1067

    
  • ·Answers to CME examination

    Page :1068

    

• Letter from the Editor

  • ·Letter from the Editor: Ensuring appropriate diversity in clinical trials

    Page :1069-1070

    Dirk M. Elston

    

• This Month in JAAD

  • ·This month in JAAD: December 2024

    Page :1071

    Dirk M. Elston

    

• This Month in JAAD Case Reports

  • ·This month in JAAD Case Reports: December 2024

    Page :1072

    Abby S. Van Voorhees

    

• This Month in JAAD International

  • ·This month in JAAD International: December 2024: Dynamic time warp analysis

    Page :1073

    Jonathan Kantor

    

• This Month in JAAD Reviews

  • ·This month in JAAD Reviews: December 2024: Pediatric alopecia areata

    Page :1074-1075

    Shari R. Lipner

    

• A Clinician's Perspective

  • ·Refining dermatomyositis

    Page :1076-1077

    Warren R. Heymann

    

• Original Articles

  • ·Approach to Mycosis Fungoides in children: Consensus-based recommendations

    Page :1078-1085

    Alex Zvulunov, Holly Neale, Jonah Stern, Pasqualina Santaguida, Amy Buros Stein, Mark Koh, Lawrence F. Eichenfield, Joan Guitart, Matthias Goebeler, Julia Scarisbrick, Rein Willemze, Carrie C. Coughlin, Renu George, Valeria Brazzelli, Márta Marschalkó, Irena Belousova, Christiane Querfeld, Martine Bagot, Jacek C. Szepietowski, Evangelina Papadavid, Pietro Quaglino, Peter Hoeger, Pablo L. Ortiz-Romero, Vasiliki Nikolaou, Reinhard Dummer, Phyu P. Aung, Leslie Lawley, Kimberly D. Morel, Bo Ngan, Mary Wain, Ana Gameiro, Rosa María Lacy-Niebla, Elena Pope

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Clinical and dermoscopic features of atypical Spitz tumors: A multicenter, retrospective, case-control study

    Page :1085

    Jane M. Grant-Kels

    

• Original Articles

  • ·Continuum of light sensitivity in atopic dermatitis: A retrospective analysis of 139 cases in Scotland

    Page :1086-1093

    Chayada Chaiyabutr, Robert Dawe, Andrea Lesar, Sally H. Ibbotson

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults

    Page :1093

    Jane M. Grant-Kels

    

• Original Articles

  • ·Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema—Findings from the Danish Skin Cohort

    Page :1094-1103

    Maria O. Christensen, Johan Sieborg, Lea K. Nymand, Emma Guttman-Yassky, Khaled Ezzedine, Christoph Schlapbach, Sonja Molin, Jianzhong Zhang, Claus Zachariae, Simon F. Thomsen, Jacob P. Thyssen, Alexander Egeberg

    Résumé Résumé Plan Plan  
  • ·Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation

    Page :1104-1112

    Iltefat H. Hamzavi, Anand K. Ganesan, Bassel H. Mahmoud, Eduardo Weiss, Ammar M. Ahmed, Deanne Robinson, Mitchel P. Goldman, Girish Munavalli, Steven A. Kahn, Victor Huang, Jill Waibel, Alpesh Desai, Nada Elbuluk, Seemal Desai, Amit G. Pandya

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Nevoid melanoma: A study of 43 cases with emphasis on growth pattern

    Page :1112

    Jane M. Grant-Kels

    

• Original Articles

  • ·Efficacy and safety of low-dose interleukin 2 in the treatment of moderate-to-severe bullous pemphigoid: A single center perspective-controlled trial

    Page :1113-1117

    Ruzeng Xue, Guomin Li, Yao Zhou, Bocheng Wang, Yingping Xu, Peizhen Zhao, Lijun Teng, Jinjin Zheng, Hongfang Liu, Suyun Ji, Dirk M. Elston, Yunsheng Liang

    Résumé Résumé Plan Plan
  • ·ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence

    Page :1118-1124

    Emily Everdell, Jenna Borok, Alana Deutsch, Ziyou Ren, Justine V. Cohen, Gabriel Molina, Sitaram Vangala, Danica McDaniel, Hensin Tsao

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Dermoscopic changes in melanocytic nevi in patients receiving immunosuppressive and biologic treatments: Results of a prospective case-control study

    Page :1124

    Jane M. Grant-Kels

    

• Original Articles

  • ·Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study

    Page :1125-1135

    Christina Boull, Yan Chen, Cindy Im, Alan Geller, Yadav Sapkota, James E. Bates, Rebecca Howell, Michael A. Arnold, Miriam Conces, Louis S. Constine, Leslie Robison, Yutaka Yasui, Gregory T. Armstrong, Joseph P. Neglia, Lucie M. Turcotte

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)

    Page :1135

    Jane M. Grant-Kels

    

• Original Articles

  • ·Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients

    Page :1136-1142

    Dirk Tomsitz, Katrin Kerl, Lars Einar French, Lucie Heinzerling

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC)

    Page :1142

    Jane M. Grant-Kels

    

• Original Articles

  • ·Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysis

    Page :1143-1149

    Bruce Strober, Ahmed M. Soliman, Chao Li, Manish Patel, Ikenna Unigwe, Paolo Gisondi

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?

    Page :1149

    Jane M. Grant-Kels

    

• Original Articles

  • ·A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement

    Page :1150-1157

    Mark Lebwohl, Michael Bukhalo, Linda Stein Gold, Brad Glick, Mar Llamas-Velasco, Samuel Sanchez-Rivera, Anqi Pan, Tianyu Zhan, Leonidas Drogaris, Kevin Douglas, Greg St. John, Ramon Espaillat, Robert Bissonnette

    Résumé Résumé Plan Plan  

• Dermatologic Surgery

  • ·Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas

    Page :1158-1166

    Katherine G. Thompson, Raghav Tripathi, Jaroslaw Jedrych, Kristin P. Bibee, Jeffrey F. Scott, Elise Ng

    Résumé Résumé Plan Plan

• JAAD Game Changers

  • ·JAAD Game Changer: Dermatologic manifestations associated with electronic cigarette use

    Page :1166

    Eden Lake

    

• From the Academy

  • ·The importance of pathway programs in increasing diversity in dermatology: Efforts made by the American Academy of Dermatology

    Page :1167-1170

    Ciara G. Robinson, Andrea Gelabert-Mora, Katrina Abuabara, Susan C. Taylor, Henry W. Lim

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changers: Functional surgery versus amputation for in situ or minimally invasive nail melanoma: A meta-analysis

    Page :1170

    Eden Lake

    

• Clinical Reviews

  • ·A sticky mess—Are moisturizers overused in dermatitis care?

    Page :1171-1176

    Susan Nedorost

    Résumé Résumé Plan Plan
  • ·Dermatologic toxicities of antibody-drug conjugates

    Page :1177-1188

    Christian Gronbeck, Matthew J. Hadfield, Jane M. Grant-Kels

    Résumé Résumé Plan Plan  

• Reviews

  • ·Integrating skin color assessments into clinical practice and research: A review of current approaches

    Page :1189-1198

    Valerie M. Harvey, Andrew Alexis, Chidubem A.V. Okeke, Lynn McKinley-Grant, Susan C. Taylor, Seemal R. Desai, Tarannum Jaleel, Candrice R. Heath, Sewon Kang, Neelam Vashi, Jenna Lester, Rebecca Vasquez, Michelle Rodrigues, Nada Elbuluk, Iltefat Hamzavi, Shawn G. Kwatra, Hema Sundaram, Caryn Cobb, Stafford G. Brown, Indermeet Kohli, Valerie D. Callender

    Résumé Résumé Plan Plan

• Research Letters

  • ·Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study

    Page :1199-1201

    Joseph F. Merola, Albert S. Chiou, Emmanuel During, Peter Foley, Jiangming Wu, Marius Ardeleanu, Zafer E. Ozturk

    Plan Plan  
  • ·Evaluation of private and Medicaid insurance coverage for port-wine stain treatment with pulsed dye laser

    Page :1201-1203

    Sophia Ly, Priya Manjaly, Lisa Y. Shen

     
  • ·Cutaneous lupus erythematosus: Expanding clinical trial eligibility criteria based on quality of life data

    Page :1203-1205

    Daniella F. Faden, Lillian Xie, Caroline J. Stone, Lais Lopes Almeida Gomes, Ahmed Eldaboush, Cristina Ricco, Rui Feng, Victoria P. Werth

     
  • ·Direct immunofluorescence testing for skin and mucosal ulcerations: A retrospective cohort study of 352 specimens

    Page :1205-1207

    Julia S. Lehman, Heather D. Hardway, Vahide Saeidi, Mark D.P. Davis, Michael J. Camilleri

    
  • ·Efficacy of colchicine treatment for aphthous ulcers in pediatric patients: A retrospective review

    Page :1207-1208

    Ananya Shah, Hilary Kunkel, Nessa Aghazadeh Mohandesi, Megha Tollefson

    
  • ·The fate of nonscalp hair in alopecia areata universalis under baricitinib treatment: A real-world single-center experience

    Page :1208-1211

    Federica Dall’Oglio, Andrea Calogero Trecarichi, Maria Rita Nasca, Francesco Lacarrubba, Anna Elisa Verzì, Giuseppe Micali

     
  • ·National trends in multimodality keloid treatment claims from 2017-2020: An IBM Marketscan study

    Page :1211-1214

    David H. Xiang, Debby Cheng, Helen Ji, Yevgeniy Semenov, Nicholas Theodosakis

    
  • ·Geographic trends in psoriasis injectable biologic prescriptions by dermatologists among Medicare beneficiaries

    Page :1214-1216

    Qiwei Wilton Sun, Hao Feng, Jeffrey M. Cohen

    
  • ·Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study

    Page :1217-1219

    Katharina S. Shaw, Kimberly B. Hashemi, Rochelle L. Castillo, Elizabeth Rainone, Allen W. Ho, Philip J. Kahn, Vikash S. Oza, Alisa Femia, Ruth Ann Vleugels

     
  • ·Prevalence and risk factors of interstitial lung disease in dermatomyositis: A retrospective study

    Page :1219-1221

    Dea Metko, Dimitra Bednar, Kimberly Legault, Mohannad Abu-Hilal

    
  • ·Allergens and consumer warnings in at-home acrylic manicure kits

    Page :1221-1223

    Hannah R. Riva, Carina M. Woodruff

    
  • ·Extrapolating the speed of psoriasis clearance: A comparative analysis of biologic agents in clinical trials

    Page :1223-1224

    Creighton Pfau, Katie K. Lovell, Steven R. Feldman

     
  • ·Central centrifugal cicatricial alopecia is associated with keloid scarring in Black women: A retrospective chart review

    Page :1225-1226

    Hailey Konisky, Raquel Klinger, Kateryna Karpoff, Eliza Balazic, Chesahna Kindred, Kseniya Kobets

    
  • ·Factors associated with adherence to skin self-examination recommendations for melanoma patients: A prospective cohort study

    Page :1226-1228

    Shannon Nugent, Annika M. Deitermann, Stephanie K. Lin, Daniel J. Lewis, Daniel B. Shin, Michael E. Ming

    
  • ·Tralokinumab as an effective alternative after dupilumab treatment failure in moderate-to-severe atopic dermatitis: A real-world study

    Page :1228-1230

    Shaina E. George, JiaDe Yu

    
  • ·Evaluating the efficacy and safety of biologic and oral drugs for refractory chronic spontaneous urticaria: Systematic review and network meta-analysis

    Page :1230-1233

    Yaxuan Zheng, Min Luo, Jiahao Huang, Marcus Maurer, Huichun Su

     
  • ·Erythema multiforme associated with the immune checkpoint inhibitors: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

    Page :1233-1234

    Hannah Godfrey, Zachary Leibovit-Reiben, Patrick Jedlowski, Rebecca Thiede

    
  • ·No association of benzoyl peroxide use with acute myeloid leukemia and hematologic malignancies in a multi-center retrospective study

    Page :1234-1236

    Ryan Chan, Katie Roster, Zachary Neubauer, Rachel C. Hill, Shari R. Lipner

    
  • ·Dermatoscopic predictors of histopathologically aggressive basal cell carcinoma and their positive impact of subtype prediction by human readers

    Page :1236-1239

    Elisa Camela, Paula Ilut Anca, Athanassios Kyrgidis, Konstantinos Lallas, Massimiliano Scalvenzi, Chryssoula Papageorgiou, Sofia-Magdalini Manoli, Theodosia Gkentsidi, Polychronia Eftychidou, Florentina Silvia Delli, Vlassios Eleftheriadis, Stella Sakellaropoulou, Ilias Papadimitriou, Iulia Maria Badiu, Ana Cutoiu, Katarzyna Korecka, Efstratios Vakirlis, Elena Sotiriou, Zoe Apalla, Aimilios Lallas

     
  • ·Educational intervention targeting primary care residents improves skin cancer recognition in patients with skin of color

    Page :1239-1240

    Jennifer J. Watters, Maria C. Bell, James E. Slaven, Syril Keena T. Que

     
  • ·A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans

    Page :1240-1242

    Pearl E. Grimes, Shanaya Dias, Angela Kyei, Tatiana V. Tatarinova, Andrew Alexis, Nada Elbuluk, Lynn Drake, Jerry Shapiro

    
  • ·A study of ultralow dose rituximab as adjuvant to standard of care in treatment of significant and extensive pemphigus vulgaris: A case series

    Page :1243-1245

    Nayankumar H. Patel, Jignaben K. Padhiyar, Jahnvi R. Patel, Kathak A. Patel, Megha P. Lakum, Yaksh Pradeep Oza, Harisiddhi Bharatbhai Patel, Prashant Bhikhabhai Chaudhary

    
  • ·Characterization of scalp involvement in dermatomyositis based on myositis-specific antibody subsets

    Page :1245-1247

    Jagmeet S. Arora, Colin M. Kincaid, Ajay N. Sharma, Natasha A. Mesinkovska, Michelle S. Min

     
  • ·Association between skin-related quality of life and race in patients with moderate-to-severe hidradenitis suppurativa: Analysis of two phase 3 clinical trials

    Page :1247-1250

    Bria Midgette, Andrew Strunk, Amit Garg

    
  • ·The role of ultraviolet-induced fluorescence dermatoscopy for the detection of multiple aggregated yellow-white globules in basal cell carcinoma

    Page :1250-1252

    Cristian Navarrete-Dechent, Pawel Pietkiewicz, Gisel Astronave, Nadeem G. Marghoob, Stephen W. Dusza, Josefina Lorenzoni, Manuela Boleira, Michael Cristopher, Rosario Aguero, Sergio Bustos, Natalia Jaimes, Maria Kurpis, Leonel Hidalgo, Alvaro Abarzua-Araya, Pablo Zoroquiain, Pablo Uribe, Consuelo Cárdenas, Katherine Droppelmann, Ashfaq A. Marghoob

     
  • ·Antihelical erythema/papules as a potential risk factor for acute and subacute interstitial pneumonia in MDA5+ dermatomyositis: A retrospective cohort study

    Page :1252-1254

    Szeman Cheung, Jiaqi Ye, Shile Chen, Mingyu Ye, Qian Zhao, Jie Zheng, Hua Cao

     
  • ·Major adverse cardiovascular events are more frequent in psoriasis patients compared to controls, despite statin therapy: An observational retrospective cohort study

    Page :1254-1256

    Ana Ormaza Vera, Alexander Yap, Kala J. Perkins-Holtsclaw, Abby S. Van Voorhees, Clinton W. Enos

    
  • ·Improved disease-specific survival in head and neck cutaneous melanomas treated with Mohs surgery over wide local excision in the United States

    Page :1256-1258

    Mitchell A. Taylor, Divya Sharma, Sierra Thomas, Erin X. Wei, Ashley Wysong

     
  • ·A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study

    Page :1258-1260

    Taoming Liu, Manman Tang, Jiao Liu, Tinghui Kong, Yuyang Tian, Sai Yang, Jiao Zhang, Suyun Ji, Zhimiao Lin, Ruzeng Xue, Yan Ding, Bin Yang, Yunsheng Liang

     
  • ·Drug survival of interleukin 17 inhibitors after switch from interleukin 23 inhibitors in psoriasis: An observational cohort study

    Page :1260-1263

    Daniella Kushnir-Grinbaum, Michael Ziv

     
  • ·Incidence of melanoma and its subtypes by census tract-level socioeconomic status: A United States population-based cohort analysis

    Page :1263-1265

    Megan Hoang, Fatima N. Mirza, Martin A. Weinstock, Abrar A. Qureshi, Eunyoung Cho

    
  • ·Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review

    Page :1265-1267

    Siddhartha Sood, Alexander Rimke, Brian D. Rankin, Abrahim Abduelmula, Jorge R. Georgakopoulos, Khalad Maliyar, Ahmed Bagit, Fernejoy Leung, Alim R. Devani, Ronald Vender, Jensen Yeung, Vimal H. Prajapati

    
  • ·Ultraviolet induced fluorescence dermoscopy in seborrheic keratosis structures

    Page :1268-1269

    Alejandro García Irigoyen, Dalit Zajdman Faitelson, Bruno Daniel Franco Rivera, Jorge Alberto Cortez Vila, Rodrigo Roldán Marín

     
  • ·Screening for cardiometabolic risk factors in patients with psoriasis and hidradenitis suppurativa: A pilot study in a safety net population

    Page :1269-1272

    Maria Elena Sanchez-Anguiano, Daniel Klufas, Erin Amerson

     
  • ·Delay in diagnosis and undertreatment of lichen sclerosus in pediatric male patients: A retrospective case series

    Page :1272-1274

    Anjie Ge, Jacob P. Reinhart, Dawn M.R. Davis, Megha M. Tollefson, Rochelle R. Torgerson, Anthony J. Mancini, Nessa Aghazadeh Mohandesi

     
  • ·Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and health care utilization: A prospective cohort study

    Page :1274-1277

    Olivia M. Haddadin, Katherine M. Erickson, Emile Latour, Jonathan Sisley, Alex G. Ortega-Loayza

     
  • ·Combination topical 5-fluorouracil 5%/calcipotriene 0.005% cream for the treatment of cutaneous in situ squamous cell carcinoma: A pilot study

    Page :1277-1278

    Riya T. Patel, Kiley K. Fagan, Eugenie Y. Quan, Nathan M. Johnson, Allison N. Tegge, Alex C. Holliday, Douglas J. Grider, Patrick S. Rush, Kyle A. Prickett, Joshua D. Eikenberg, Mariana A. Phillips

    
  • ·Nail pigmentation may be an early sign of minocycline-associated cutaneous pigmentation: A systematic review

    Page :1278-1281

    Eden Axler, Shilpa Malik, Angela Lu, Sungmin Hong, Amar D. Desai, Sofia Malik, Shari R. Lipner

     
  • ·Examining blood pressure changes with spironolactone for alopecia: A retrospective analysis

    Page :1281-1282

    Deesha Desai, Ambika Nohria, Michelle Sikora, Nnaemeka Anyanwu, Avrom S. Caplan, Michael Garshick, Jerry Shapiro, Kristen I. Lo Sicco

     
  • ·Dupilumab is associated with reduced risk of acute upper respiratory infections in patients with atopic dermatitis compared with nontargeted immunosuppressants: A multicenter cohort study

    Page :1282-1284

    Emily Z. Ma, Aaron Bao, Michael Ahmadi, Jeni Zhang, Shawn G. Kwatra

    
  • ·ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making

    Page :1284-1286

    Neil Jairath, Sophia Manduca, Syril Keena T. Que

    
  • ·Bisphosphonates are associated with low adverse events in dermatologic patients on glucocorticoid therapy

    Page :1286-1287

    Philippe Jean-Pierre, Rachel R. Lin, Scott A. Elman

    
  • ·Patient satisfaction with teledermatology: A systematic review and meta-analysis

    Page :1288-1289

    Michael J. Diaz, Jasmine T. Tran, Isabella M. Mark, Dang Nguyen, Mahtab Forouzandeh, Shari R. Lipner, Jane M. Grant-Kels, Abel Torres, Kiran Motaparthi, Marjorie E. Montanez-Wiscovich, Benjamin H. Kaffenberger

    
  • ·Frailty and functional dependency in a multicenter cohort of older adults with psoriasis: Prevalence and extent of and implications for psoriasis management

    Page :1289-1293

    Elke L.M. ter Haar, Juul M.P.A. van den Reek, Mahshid Sadat Chenarani Moghadam, Yvonne Schoon, Marloes M. Kleinpenning, Elke M.G.J. de Jong, Satish F.K. Lubeek

    
  • ·Diagnostic value of direct immunofluorescence testing in the evaluation of alopecia: A single-institution retrospective cohort study of 346 specimens

    Page :1293-1295

    Michelle D. Colbert, Giang H. Nguyen, Carilyn N. Wieland, Michael J. Camilleri, Heather Hardway, Julia S. Lehman

    
  • ·All that is red is not cellulitis: Retrospective application of the ALT-70 scoring system in patients diagnosed with cellulitis in the emergency department by nondermatologists

    Page :1295-1296

    Sweta Subhadarshani, Anastasia Tambovtseva, Taylor Griffith, Layal Antoury, Cristobal Cintron, Jeffery Durbin, Alan Hamza

    
  • ·Decoupling the association of dupilumab with cutaneous T-cell lymphoma

    Page :1296-1298

    Zachary J.K. Neubauer, Patrick M. Brunner, Larisa J. Geskin, Emma Guttman, Shari R. Lipner

    

• Humanities

  • ·Color me unhealthy: The toxic health effects of colorism

    Page :1299-1300

    Kathyana P. Santiago Mangual, Heather Gochnauer, Arianne Shadi Kourosh

    

• Commentary

  • ·Nicotinamide for high-risk skin cancer patients: An update

    Page :1301-1302

    Karynne O. Duncan, Eveline O. Stock, Diona L. Damian, Stanley J. Miller

    

• JAAD Game Changers

  • ·JAAD Game Changer: Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms

    Page :1302

    Eden Lake

    

• Ethics Journal Club

  • ·Equitable distribution of research opportunities to medical students

    Page :1303-1304

    Jesper Ke, Severine Z. Cao, Allison M. Darland, Jane M. Grant-Kels, Julie E. Mervak

    

• JAAD Game Changers

  • ·JAAD Game Changer: Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field

    Page :1304

    Eden Lake

    

• Ethics Journal Club

  • ·Ethical issues of a patient refusing a full body skin examination

    Page :1305-1306

    LeeAnn Meadows, Richard W. Hempstead, Jane M. Grant-Kels

    

• JAAD Game Changers

  • ·JAAD Game Changer: Optimizing the total-body skin exam: An observational cohort study

    Page :1306

    Eden Lake

    

• Ethics Journal Club

  • ·The ethics of artificial intelligence-driven diagnostic testing in dermatology

    Page :1307-1308

    Sonal Muzumdar, Jane M. Grant-Kels

    

• JAAD Game Changers

  • ·JAAD Game Changers: Patient satisfaction and physician productivity in shared medical appointments for vitiligo

    Page :1308

    Eden Lake

    

• Correction

  • ·Correction

    Page :1309

    
  • ·Correction

    Page :1310

    

• JAAD Online

  • ·Handmade double-blade scalpel for Mohs surgery

    Page :e155

    Pedro Gil-Pallares, Mariana Claudia Matei, Marcial Álvarez-Salafranca, Alejandro Vilas-Sueiro, Alba Navarro-Bielsa, Yolanda Gilaberte

    Plan Plan  
  • ·Implementing Apple AirTag to provide real-time tracking of histopathology specimens during transportation

    Page :e157

    Sujitha Yadlapati, Drew Taylor, Stanislav N. Tolkachjov

    Plan Plan  
  • ·Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’

    Page :e161

    Aoife Boyle, Ian McDonald, Dmitri Wall

    
  • ·Cost-utility and actionability of genomic sequencing for inflammatory linear verrucous epidermal nevus

    Page :e163

    James P. Pham, Deshan F. Sebaratnam

     
  • ·Boosting GPT-4V's accuracy in dermoscopic classification with few-shot learning. Comment on “can ChatGPT vision diagnose melanoma? An exploratory diagnostic accuracy study”

    Page :e165

    Jinge Wang, Gangqing Hu

    Plan Plan  
  • ·Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab

    Page :e167

    Tai-Li Chen, Sheng-Hsiang Ma

    
  • ·Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

    Page :e169

    Khalaf Kridin, Ralf J. Ludwig

    
  • ·Response to “No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study”

    Page :e171

    Deesha Desai, Michelle Sikora, Ambika Nohria, Avrom S. Caplan, Mario Lacouture, Jerry Shapiro, Kristen I. Lo Sicco

    
  • ·Future research directions regarding safety of spironolactone for dermatologic conditions

    Page :e173

    Rachel C. Hill, Yu Wang, Bilal Shaikh, Shari R. Lipner

    
  • ·Response to Vu et al, “Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study”

    Page :e175

    Sumir Chawla, Neil P. Patel

    
  • ·Response to Chawla et al, “Response to Vu et al’s “Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study””

    Page :e177

    Don Vu, Megan Park, Raed Alhusayen

    
  • ·Response to: Bocquel et al, “Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study”

    Page :e179

    Hui Xin See Tow, Agnes Yeok-Loo Lim, Ci-En Ellie Choi

    
  • ·Reaction on permanent make-up: Don't forget sarcoidosis!

    Page :e181

    Nicolas Kluger

    
  • ·Correction to excision margins for melanoma in situ on the head and neck

    Page :e183

    Richard Bennett

    
  • ·Response to Bennett et al., “[Correction to excision margins for melanoma in situ on the head and neck]”

    Page :e185

    Divya Srivastava, Rajiv I. Nijhawan

    
  • ·Response to Costa Fechine et al’s “Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study”

    Page :e187

    Jeffrey N. Li, Andrea Sechi, Antonella Tosti

    
  • ·Response to Li et al, “[Response to Costa Fechine et al, “Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study].”

    Page :e189

    Carolina O.C. Fechine, Neusa Y.S. Valente, Ricardo Romiti

    
  • ·December 2024 iotaderma (#370)

    Page :e191

    Robert I. Rudolph